Compare JPMorgan Equity Premium Income ETF (JEPI) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Equity Premium Income ETF vs Koninklijke Philips NV — how do they compare? JPMorgan Equity Premium Income ETF trades at $57.77, while Koninklijke Philips NV trades at $26.66 (market cap $26.58B). The key difference: Koninklijke Philips NV pays a 3.75% dividend while JPMorgan Equity Premium Income ETF pays none, and JPMorgan Equity Premium Income ETF is trading nearer its 52-week high, Koninklijke Philips NV nearer its low. Which is the better fit depends on your goals.
| JEPI | PHG | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $59.88 | $32.91 |
52-Week Low | $55.29 | $25.02 |
Market Cap | — | $26.58B |
Enterprise Value | — | $33.13B |
Dividend Yield | — | 3.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JEPI trades at $57.8, up 0.28% today, with a bullish technical signal driven by moving averages. The ETF focuses on generating income through covered calls, offering monthly dividends, but key valuation ratios are not publicly disclosed. Recent news highlights its popularity among retirees for yield, though some articles note underperformance versus peers.
Outlook is mixed: strong income appeal supports demand, but competition and potential tax inefficiencies pose risks. Investors should weigh the high yield against total return lag and market volatility exposure. The bullish technical trend may face resistance near current levels if overbought conditions persist.
PHG trades at $26.94, up 0.79% with bullish technical signals and strong earnings beats in recent quarters. The company shows improving fundamentals with 2025 net income of $895M (5.01% margin) and positive cash flow trends. Recent news highlights Exor's increased stake flexibility and institutional buying interest, supporting positive sentiment despite some order timing challenges.
The outlook remains constructive with analyst consensus leaning positive (40.9% buy ratings) and improving profitability. Key risks include competitive pressures and macroeconomic headwinds, but solid execution and shareholder support provide stability for medium-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
